Overview

Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the effect of vitamin E on preventing from incidence of contrast induced acute kidney injury (CI-AKI) in the patients who undergone coronary angiography.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Urmia University of Medical Sciences
Treatments:
alpha-Tocopherol
Tocopherols
Tocotrienols
Vitamin E
Vitamins
Criteria
Inclusion Criteria:

1. All patients whon have either stable coronary artery disease (CAD) or recent acute
coronary disease (ACS) and are scheduled for coronary angiography.

2. Patients who have eGFR ≤60 ml/min/1.73 m2

Exclusion Criteria:

1. Allergy to contrast media

2. Cardiogenic shock

3. Pulmonary edema

4. Overt cardiac failure or left ventricular ejection fraction ≤ 30%

5. Acute kidney injury

6. The history of receiving contrast media for any medical diagnostic or therapeutic
procedures during previous 5 days

7. The history of dialysis

8. Being pregnant

9. Having recent acute myocardial infarction

10. Taking antioxidants and nephrotoxic drugs including NSAID and ACE-I on previous 2 days